594 related articles for article (PubMed ID: 16344523)
21. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
22. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
[TBL] [Abstract][Full Text] [Related]
23. Inclusion body myositis: an underdiagnosed myopathy of older people.
Munshi SK; Thanvi B; Jonnalagadda SJ; Da Forno P; Patel A; Sharma S
Age Ageing; 2006 Jan; 35(1):91-4. PubMed ID: 16364943
[TBL] [Abstract][Full Text] [Related]
24. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
[TBL] [Abstract][Full Text] [Related]
25. Potential therapeutic targets for idiopathic inflammatory myopathies.
De Bleecker JL; Creus KK; De Paepe B
Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
[TBL] [Abstract][Full Text] [Related]
26. Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
Am J Hematol; 2001 May; 67(1):20-6. PubMed ID: 11279653
[TBL] [Abstract][Full Text] [Related]
27. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
Tateyama M; Fujihara K; Misu T; Itoyama Y
J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
29. Evidence for MHC I-restricted CD8+ T-cell-mediated immunopathology in canine masticatory muscle myositis and polymyositis.
Neumann J; Bilzer T
Muscle Nerve; 2006 Feb; 33(2):215-24. PubMed ID: 16270307
[TBL] [Abstract][Full Text] [Related]
30. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
Dalakas MC
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
[TBL] [Abstract][Full Text] [Related]
31. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
32. [Recent progress of molecular immunology on inflammatory myopathy].
Higuchi I; Osame M
Nihon Rinsho; 1997 Dec; 55(12):3331-5. PubMed ID: 9436459
[TBL] [Abstract][Full Text] [Related]
33. Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells.
Pandya JM; Fasth AE; Zong M; Arnardottir S; Dani L; Lindroos E; Malmström V; Lundberg IE
Arthritis Rheum; 2010 Nov; 62(11):3457-66. PubMed ID: 20662057
[TBL] [Abstract][Full Text] [Related]
34. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.
Sugihara T; Sekine C; Nakae T; Kohyama K; Harigai M; Iwakura Y; Matsumoto Y; Miyasaka N; Kohsaka H
Arthritis Rheum; 2007 Apr; 56(4):1304-14. PubMed ID: 17394136
[TBL] [Abstract][Full Text] [Related]
35. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies.
Lindberg C; Oldfors A; Tarkowski A
Eur J Immunol; 1994 Nov; 24(11):2659-63. PubMed ID: 7957558
[TBL] [Abstract][Full Text] [Related]
36. Review: An update on inflammatory and autoimmune myopathies.
Dalakas MC
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
[TBL] [Abstract][Full Text] [Related]
37. [Pathogenesis of primary inflammatory myopathies].
Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
[TBL] [Abstract][Full Text] [Related]
38. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis.
Dion E; Cherin P; Payan C; Fournet JC; Papo T; Maisonobe T; Auberton E; Chosidow O; Godeau P; Piette JC; Herson S; Grenier P
J Rheumatol; 2002 Sep; 29(9):1897-906. PubMed ID: 12233884
[TBL] [Abstract][Full Text] [Related]
40. Sporadic inclusion body myositis: a continuing puzzle.
Needham M; Mastaglia FL
Neuromuscul Disord; 2008 Jan; 18(1):6-16. PubMed ID: 18160291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
